Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news ...
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
The Food and Drug Administration on Friday said the shortage of Novo ... of cheaper compounded versions of the wildly ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...